Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Market Cap	647.73B +15.1%
Revenue (ttm)	353.39B +9.7%
Net Income	33.13B -3.4%
EPS	140.53 -6.2%
Shares Out	225.96M
PE Ratio	20.40
Forward PE	18.21
Dividend	50.00 (1.80%)
Ex-Dividend Date	Sep 29, 2026

Volume	1,044,000
Open	2,880.00
Previous Close	2,867.00
Day's Range	2,856.50 - 2,901.50
52-Week Range	2,218.50 - 2,918.50
Beta	-0.46
Analysts	Buy
Price Target	2,975.45 (+3.8%)
Earnings Date	Aug 6, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 9,292
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In fiscal year 2026, Rohto Pharmaceutical's revenue was 343.73 billion, an increase of 11.37% compared to the previous year's 308.63 billion. Earnings were 34.25 billion, an increase of 10.45%.

Analyst Summary

According to 11 analysts, the average rating for 4527 stock is "Buy." The 12-month stock price target is ¥2,975, which is an increase of 3.80% from the latest price.

Price Target

¥2,975

(3.80% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error